experimental group:TCM formula and general treatment based on "Diagnosis and Treatment Program for COVID-19" (trial version 6th)

2 trials

Sponsors

China Academy of Chinese Medical Sciences

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Unknown Phase

Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial

RecruitingITMCTR2000003059

China Academy of Chinese Medical SciencesNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-27Updated: 2023-02-20

Efficacy of Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled Trial

RecruitingChiCTR2000030288

China Academy of Chinese Medical SciencesNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-02-27Updated: 2020-03-30

Related Papers

Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trial.

2021-07-1752 citations